Cargando…
Triplet Chemotherapy with Cisplatin versus Oxaliplatin in the CRITICS Trial: Treatment Compliance, Toxicity, Outcomes and Quality of Life in Patients with Resectable Gastric Cancer
SIMPLE SUMMARY: Perioperative chemotherapy is the current standard treatment for patients with resectable gastric cancer. Either cisplatin or oxaliplatin could be part of the chemotherapy regimen, of which oxaliplatin is currently most used in the standard treatment. Evidence to choose oxaliplatin o...
Autores principales: | Slagter, Astrid E., Caspers, Irene A., van Grieken, Nicole C. T., Walraven, Iris, Lind, Pehr, Meershoek-Klein Kranenbarg, Elma, Grootscholten, Cecile, Nordsmark, Marianne, van Sandick, Johanna W., Sikorska, Karolina, van de Velde, Cornelis J. H., Jansen, Edwin P. M., Verheij, Marcel, van Laarhoven, Hanneke W. M., Cats, Annemieke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9221508/ https://www.ncbi.nlm.nih.gov/pubmed/35740628 http://dx.doi.org/10.3390/cancers14122963 |
Ejemplares similares
-
Venous thromboembolism during preoperative chemotherapy in the CRITICS gastric cancer trial
por: Slagter, Astrid E., et al.
Publicado: (2020) -
Risk Factors for Metachronous Isolated Peritoneal Metastasis after Preoperative Chemotherapy and Potentially Curative Gastric Cancer Resection: Results from the CRITICS Trial
por: Caspers, Irene A., et al.
Publicado: (2021) -
Prognostic value of tumor markers and ctDNA in patients with resectable gastric cancer receiving perioperative treatment: results from the CRITICS trial
por: Slagter, Astrid E., et al.
Publicado: (2021) -
Towards Personalization in the Curative Treatment of Gastric Cancer
por: Slagter, Astrid E., et al.
Publicado: (2020) -
Neo-adjuvant chemotherapy followed by surgery and chemotherapy or by surgery and chemoradiotherapy for patients with resectable gastric cancer (CRITICS)
por: Dikken, Johan L, et al.
Publicado: (2011)